ARCHITECT TOTAL PSA
Report
- Report Number
- 3008344661-2022-00107
- Event Type
- Malfunction
- Date Received
- September 9, 2022
- Date of Event
- August 11, 2022
- Report Date
- November 8, 2022
- Manufacturer
- ABBOTT IRELAND
- Product Code
- MTF
- PMA / PMN Number
- P910007
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
ALL AVAILABLE PATIENT INFORMATION IS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 7K70 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 6C06. AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.
AFTER FURTHER EVALUATION, THE SUSPECT MEDICAL DEVICE WAS CHANGED FROM ARCHITECT TOTAL PSA, 07K70-35, ABBOTT IRELAND - SLIGO TO ARCHITECT I2000SR, 03M74-02, ABBOTT LABORATORIES - IRVING, TEXAS. MDR NUMBER 3016438761-2022-00515-00 HAS BEEN SUBMITTED AND ALL FURTHER INFORMATION WILL BE DOCUMENTED UNDER THAT MDR NUMBER. H3 OTHER TEXT : AFTER FURTHER EVALUATION, THE SUSPECT MEDICAL DEVICE WAS CHANGED FROM ARCHITECT TOTAL PSA, 07K70-35, ABBOTT IRELAND - SLIGO TO ARCHITECT I2000SR, 03M74-02, ABBOTT LABORATORIES - IRVING, TEXAS. MDR NUMBER 3016438761-2022-00515-00 HAS BEEN SUBMITTED AND ALL FURTHER INFORMATION WILL BE DOCUMENTED UNDER THAT MDR NUMBER.
THE CUSTOMER REPORTED A FALSELY DECREASED ARCHITECT TOTAL PSA (PROSTATE SPECIFIC ANTIGEN) RESULT FOR A PATIENT WHILE USING THE ARCHITECT I2000SR ANALYZER. ON (B)(6) 2022, A PSA SAMPLE (SID (B)(6)) RESULT WAS > 100 NG/ML. THE SAMPLE WAS THEN AUTOMATICALLY DILUTED BY THE INSTRUMENT AND VALUE GENERATED TO BE < 0.08 NG/ML. SINCE THE CUSTOMER USES AUTO-VALIDATIONS OF RESULTS, THE < 0.08 NG/ML WAS RELEASED TO THE PATIENT. PATIENT/CLINICIAN QUESTIONED THE DECREASED RESULT AS IT DID NOT CORRELATE WITH THE PATIENT¿S CLINICAL PICTURE. A FRESH SAMPLE WAS COLLECTED FROM THE PATIENT AND RUN DIRECTLY WITH DILUTION PROTOCOL WHERE THE RESULT GENERATED A VALUE OF 540.665 NG/ML. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1139762 | ARCHITECT TOTAL PSA | TOTAL, PROSTATE SPECIFIC AG (NONCOMPLEXED/COMPLEXED) FOR DET OF PROSTATE CANCER | MTF | ABBOTT IRELAND | 35138FN00 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | ARC I2000SR INST, 03M74-02, (B)(6) | ARC I2000SR INST, 03M74-02, (B)(6) |